The effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa’s Eastern Cape Province-Reference-Cited by-同舟云学术

The effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa’s Eastern Cape Province

Published:2017-01-21 Issue:1 Volume:17 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Iruedo Joshua,O’Mahony Don,Mabunda Sikhumbuzo,Wright Graham,Cawe Busisiwe

Funder

Discovery Foundation

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-017-2200-8.pdf

Reference41 articles.

1. World Health Organization. Global Tuberculosis Report 2015. Geneva: World Health Organization; 2015.

2. World Health Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). Geneva: World Health Organization; 2008.

3. Helb D, Jones M, Story E, Boehme C, Wallace E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010;48:229–37.

4. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011;377:1495–505.

5. Department of Health. Management of Drug-Resistant Tuberculosis. Policy Guidelines (Updated - January 2013). Pretoria: Department of Health; 2013.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance evaluation of the Xpert MTB/XDR test for the detection of drug resistance to Mycobacterium tuberculosis among people diagnosed with tuberculosis in South Africa;Journal of Clinical Microbiology;2024-08-14

2. Sources of knowledge empowerment amongst pregnant women with TB disease: A qualitative study in South Africa;Health Expectations;2023-12-26

3. Pediatric multi-drug-resistant tuberculosis in Germany – diagnostic and therapeutic challenges of an “orphan disease”;European Journal of Pediatrics;2023-09-14

4. Time to Treatment and Risk Factors for Unsuccessful Treatment Outcomes among People Who Started Second-Line Treatment for Rifampicin-Resistant or Multi-Drug-Resistant Tuberculosis in the Kyrgyz Republic, 2021;Tropical Medicine and Infectious Disease;2023-08-10

5. Drug resistant tuberculosis treatment service alignment with health seeking behaviour in selected states in Nigeria;Journal of Public Health and Epidemiology;2023-07-31